The advent of an immunotherapy to delay type 1 diabetes and more potential treatments in the pipeline have shifted the way ...
Aya Gold & Silver Inc. (TSX: AYA; NASDAQ: AYA) (“Aya” or the “Company”) is pleased to provide an update on workstreams supporting the Feasibility Study (“FS”) for the Boumadine Project (“Boumadine”), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results